J. William Higgins

2.3k total citations · 1 hit paper
20 papers, 1.5k citations indexed

About

J. William Higgins is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. William Higgins has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J. William Higgins's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). J. William Higgins is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). J. William Higgins collaborates with scholars based in United States, United Kingdom and Canada. J. William Higgins's co-authors include Maciej J. Zamek‐Gliszczynski, Jing Bao, Ewan E. Morrison, Jacquelyn Bond, Alice Ke, C. Geoffrey Woods, Christopher Bennett, Emma Roberts, Sharon C. Presnell and Stephen D. Hall and has published in prestigious journals such as Nature Genetics, Nature Materials and PLoS ONE.

In The Last Decade

J. William Higgins

19 papers receiving 1.5k citations

Hit Papers

Cellular extrusion bioprinting improves kidney organoid r... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. William Higgins United States 14 728 448 344 304 235 20 1.5k
Guy Makin United Kingdom 23 969 1.3× 537 1.2× 150 0.4× 101 0.3× 133 0.6× 49 1.8k
Robert D. Bruno United States 20 450 0.6× 508 1.1× 99 0.3× 439 1.4× 207 0.9× 34 1.4k
Jung‐Hwa Oh South Korea 21 866 1.2× 223 0.5× 80 0.2× 156 0.5× 166 0.7× 69 1.4k
Hae‐Yun Jung South Korea 20 823 1.1× 505 1.1× 186 0.5× 75 0.2× 65 0.3× 31 1.5k
Judith Hagenbuchner Austria 21 980 1.3× 182 0.4× 107 0.3× 118 0.4× 38 0.2× 38 1.4k
Jiangchao Li China 22 963 1.3× 368 0.8× 90 0.3× 52 0.2× 48 0.2× 72 1.6k
Xuejian Zhao China 25 868 1.2× 408 0.9× 141 0.4× 259 0.9× 150 0.6× 62 1.7k
Vivi Kasim China 24 1.3k 1.8× 253 0.6× 137 0.4× 99 0.3× 104 0.4× 62 1.9k
Nicolas Germain France 20 519 0.7× 160 0.4× 45 0.1× 87 0.3× 68 0.3× 41 1.4k
Houjie Liang China 29 1.2k 1.7× 711 1.6× 174 0.5× 175 0.6× 97 0.4× 73 2.4k

Countries citing papers authored by J. William Higgins

Since Specialization
Citations

This map shows the geographic impact of J. William Higgins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. William Higgins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. William Higgins more than expected).

Fields of papers citing papers by J. William Higgins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. William Higgins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. William Higgins. The network helps show where J. William Higgins may publish in the future.

Co-authorship network of co-authors of J. William Higgins

This figure shows the co-authorship network connecting the top 25 collaborators of J. William Higgins. A scholar is included among the top collaborators of J. William Higgins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. William Higgins. J. William Higgins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Keith E., J. William Higgins, Sara Brin Rosenthal, et al.. (2024). Induction of MASH in three-dimensional bioprinted human liver tissue. PLoS ONE. 19(12). e0312615–e0312615. 1 indexed citations
2.
Martin, Heather L., J. William Higgins, Anna A. Tang, et al.. (2023). Affimer-mediated locking of p21-activated kinase 5 in an intermediate activation state results in kinase inhibition. Cell Reports. 42(10). 113184–113184. 3 indexed citations
3.
Coe, Kevin J., Mark Feinstein, J. William Higgins, et al.. (2022). Characterization of JNJ-2482272 [4-(4-Methyl-2-(4-(Trifluoromethyl)Phenyl)Thiazole-5-yl) Pyrimidine-2-Amine] As a Strong Aryl Hydrocarbon Receptor Activator in Rat and Human. Drug Metabolism and Disposition. 50(8). 1064–1076. 2 indexed citations
4.
Lawlor, Kynan T., Jessica M. Vanslambrouck, J. William Higgins, et al.. (2020). Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation. Nature Materials. 20(2). 260–271. 310 indexed citations breakdown →
5.
King, Shelby M., et al.. (2017). 3D Proximal Tubule Tissues Recapitulate Key Aspects of Renal Physiology to Enable Nephrotoxicity Testing. Frontiers in Physiology. 8. 123–123. 93 indexed citations
6.
Posada, Maria M., Ellen A. Cannady, Christopher D. Payne, et al.. (2017). Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib. Clinical and Translational Science. 10(6). 509–519. 55 indexed citations
7.
King, Shelby M., et al.. (2016). A three-dimensional (3D) bioprinted model of the renal proximal tubule for evaluation of drug-induced nephrotoxicity. Toxicology Letters. 258. S288–S288. 1 indexed citations
8.
Martin, Heather L., Matthew Adams, J. William Higgins, et al.. (2014). High-Content, High-Throughput Screening for the Identification of Cytotoxic Compounds Based on Cell Morphology and Cell Proliferation Markers. PLoS ONE. 9(2). e88338–e88338. 55 indexed citations
9.
Higgins, J. William, Alice Ke, & Maciej J. Zamek‐Gliszczynski. (2014). Clinical CYP3A Inhibitor Alternatives to Ketoconazole, Clarithromycin and Itraconazole, Are Not Transported into the Liver by Hepatic Organic Anion Transporting Polypeptides and Organic Cation Transporter 1. Drug Metabolism and Disposition. 42(11). 1780–1784. 16 indexed citations
10.
Ke, Alice, et al.. (2014). Itraconazole and Clarithromycin as Ketoconazole Alternatives for Clinical CYP3A Inhibition Studies. Clinical Pharmacology & Therapeutics. 95(5). 473–476. 50 indexed citations
11.
Posada, Maria M., James A. Bacon, Karen Schneck, et al.. (2014). Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling. Drug Metabolism and Disposition. 43(3). 325–334. 54 indexed citations
12.
Adams, Matthew, Victoria Cookson, J. William Higgins, et al.. (2013). A High-Throughput Assay to Identify Modifiers of Premature Chromosome Condensation. SLAS DISCOVERY. 19(1). 176–183. 8 indexed citations
13.
Zamek‐Gliszczynski, Maciej J., Jing Bao, Jeffrey S. Day, & J. William Higgins. (2013). Metformin Sinusoidal Efflux from the Liver Is Consistent with Negligible Biliary Excretion and Absence of Enterohepatic Cycling. Drug Metabolism and Disposition. 41(11). 1967–1971. 23 indexed citations
15.
Higgins, J. William, et al.. (2012). Ablation of Both Organic Cation Transporter (Oct)1 and Oct2 Alters Metformin Pharmacokinetics but Has No Effect on Tissue Drug Exposure and Pharmacodynamics. Drug Metabolism and Disposition. 40(6). 1170–1177. 88 indexed citations
16.
Zamek‐Gliszczynski, Maciej J., et al.. (2012). Characterization of SAGE Mdr1a (P-gp), Bcrp, and Mrp2 Knockout Rats Using Loperamide, Paclitaxel, Sulfasalazine, and Carboxydichlorofluorescein Pharmacokinetics. Drug Metabolism and Disposition. 40(9). 1825–1833. 81 indexed citations
17.
Higgins, J. William, Carol Midgley, Sandra Bell, et al.. (2010). Human ASPM participates in spindle organisation, spindle orientation and cytokinesis. BMC Cell Biology. 11(1). 85–85. 95 indexed citations
18.
Gannon, Michael K., Stephanie M. Bennett, Tip W. Loo, et al.. (2009). Rhodamine Inhibitors of P-Glycoprotein: An Amide/Thioamide “Switch” for ATPase Activity. Journal of Medicinal Chemistry. 52(10). 3328–3341. 54 indexed citations
19.
Sawada, Geri A., et al.. (2008). Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells. Bioorganic & Medicinal Chemistry. 16(22). 9745–9756. 13 indexed citations
20.
Bond, Jacquelyn, Emma Roberts, Kelly Springell, et al.. (2005). A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nature Genetics. 37(4). 353–355. 423 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026